|
8:00 - 11:00 am PART I: The Challenge of Targeting Ion Channels for Therapeutic Benefit
Topics to be Discussed:
Safety Emerging Targets Lead Generation
Gregory J. Kaczorowski, Ph.D., President, CEO, Kanalis Consulting; Adjunict Professor, Physiology and Pharmacology, New Jersey Medical School
Maria Kaczorowski, Ph.D., Consultant
12:00 - 3:00 pm PART II: Ion Channel Assays for Safety Screening
Overview of current and emerging assays and methodologies Use of automation and high-throughput techniques Comparison of platforms and applications Factors affecting sensitivity and specificity
3:30 – 6:30 pm PART III: Automatic Patch Clamp for Ion Channel Screening
Chris Mathes, Ph.D.,Vice President & General Manager, North America, Sophion Bioscience, Inc.
|
Download
